{"id":"W4410810218","doi":"10.1200/jco.2025.43.16_suppl.e12598","title":"A phase 1 study of abemaciclib and niraparib as neoadjuvant therapy in hormone receptor positive and HER2 negative breast cancer.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Hormone receptor; Internal medicine; Cancer; Hormone therapy; Neoadjuvant therapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001221189,0.001254129,0.002420611,0.0005957264,0.0004642679,0.001025073,0.001119167,0.001346348,0.005243642],"category_scores_gemma":[0.0007687232,0.0008542923,0.001040057,0.000572429,0.0007749031,0.0009141215,0.0004052381,0.002917869,0.001270822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001125779,"about_ca_system_score_gemma":0.002284744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001137275,"about_ca_topic_score_gemma":0.003889105,"domain_scores_codex":[0.9996137,0.0001749491,0.00002230797,0.00007080402,0.00004815934,0.00007016103],"domain_scores_gemma":[0.9995104,0.00005850052,0.00008279659,0.00005226489,0.00004481641,0.0002512299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6910465,0.1701901,0.003553537,0.00125505,0.0008575625,0.0002963192,0.0002690853,0.002120274,0.04208736,0.0004438256,0.004539431,0.08334091],"study_design_scores_gemma":[0.5184671,0.4654515,0.005890935,0.00005176765,0.0003083169,0.0003730687,0.00006329852,0.0008679489,0.003235764,0.000221233,0.005038959,0.00003011379],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9768468,0.003338613,0.0006918201,0.0006091378,0.0002788305,0.01147205,0.002057759,0.0001212071,0.004583939],"genre_scores_gemma":[0.9662832,0.004249442,0.003992945,0.001408026,0.0002580055,0.01184744,0.004351491,0.00004950847,0.007559897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005243642,"threshold_uncertainty_score":0.01754171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06079761404456113,"score_gpt":0.497628338165247,"score_spread":0.4368307241206859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}